DBV Technologies (DBVT) Change in Account Payables (2020 - 2026)
DBV Technologies (DBVT) posted Change in Account Payables of $100000.0 for Q2 2026, up 120.0% sequentially from -$500000.0 in Q1 2026, and down 97.5% YoY from $4.0 million in Q2 2025.
DBV Technologies (DBVT) Change in Account Payables (2020 - 2026) Analysis & Trends
DBV Technologies has reported Change in Account Payables for 7 years, with the latest figure at $100000.0 in Q2 2026.
- Quarterly Change in Account Payables fell 97.5% year-over-year to $100000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $483000.0 (down 97.35% YoY) and the FY2025 annual result came in at $15.8 million, up 5702.57% from the prior year.
- Change in Account Payables rose to $100000.0 in Q2 2026 per DBVT's latest filing, from -$500000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $10.9 million in Q1 2025 and troughed at -$4.8 million in Q1 2024.
- A 5-year average of $1.5 million and a median of $731000.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 23668.42% in 2023, down 786.15% in 2023.
- Over 5 years, Change in Account Payables stood at -$2.2 million in 2022, then soared by 400.0% to $6.7 million in 2023, then sank by 79.76% to $1.4 million in 2024, then climbed by 10.13% to $1.5 million in 2025, then plunged by 93.33% to $100000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $100000.0, -$500000.0, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | -617,000.00 |
| Sep 30, 2025 | -617,000.00 |
| Jun 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | -4.81 Mn |
| Mar 31, 2024 | -4.81 Mn |